Tenaya Therapeutics, Inc. TNYA
0.37 USD +0.01 (+2.66%)
At closeNov 4, 2026, 5:03 PM EST
0.38 +0.01 +3.95%
After hours · Nov 4, 5:03 PM ET
0.3658 Day range 0.3827
0.351 52-week range 1.56
- YTD
- -48.05%
- 1 year
- -73.20%
Financial health
Altman Z-Score
-1.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -1.2×
FY 2019 5y median -1.2× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.9×
FY 2019 5y median 1.3× FY 2025
P/FCF -1.6×
FY 2019 5y median -1.6× FY 2025
EV/EBITDA -0.2×
FY 2019 5y median -1.3× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -63.3%
FY 2019 5y median -63.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -73.5%
FY 2019 5y median -73.5% FY 2025
ROIC -69.4%
FY 2019 5y median -69.4% FY 2025
ROA -61.7%
FY 2019 5y median -61.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 19.5%
FY 2019 FY 2025
EPS (diluted) 55.0%
FY 2019 FY 2025
Free Cash Flow 24.7%
FY 2019 FY 2025
Financial Health
Current Ratio 6.8×
FY 2019 5y median 6.8× FY 2025
Quick Ratio 6.8×
FY 2019 5y median 6.8× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 1.1×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31